MANIFESTAÇÕES CUTÂNEAS E CLÍNICAS EM PACIENTES DIAGNOSTICADOS COM COVID-19 NA AMAZÔNIA: SÉRIE DE CASOS

In 2019, a new obscured pneumonia was reported by Wuhan Chinese scientists. Posteriorly, SARS-Cov-2 structure was identified, furthermore the pathology caused by this virus was named as COVID-19. The period of incubation of this disease is something about 4 or 5 days before the onset of symptoms, with 97,5% of patients having 11,5 days of symptoms nearly. Furthermore, affected patients are having cutaneous manifestations, in addition to the classic pulmonary, laboratorial, and systemic affection. Thus, the goal of the present article was the description of the clinical, cutaneous and laboratorial manifestations in adults of 18 to 59 years old affected by COVID19 and supported by São Rafael hospital, localized in Altamira- Pará, a region of AmazonEn 2019, científicos chinos de Wuhan informaron de una nueva neumonía oscurecida. Posteriormente, se identificó la estructura del SARS-Cov-2, además la patología causada por este virus fue denominada como COVID-19. El período de incubación de esta enfermedad es algo así como 4 o 5 días antes de la aparición de los síntomas, con un 97,5% de los pacientes que tienen casi 11,5 días de síntomas. Además, los pacientes afectados están teniendo manifestaciones cutáneas, además de la clásica afección pulmonar, de laboratorio y sistémica. Por lo tanto, el objetivo del presente artículo fue la descripción de las manifestaciones clínicas, cutáneas y de laboratorio en adultos de 18 a 59 años afectados por COVID19 y apoyados por el hospital São Rafael, localizado en Altamira-Pará, una región de la Amazonía.Em 2019, uma nova pneumonia obscurecida foi relatada por cientistas chineses de Wuhan. Posteriormente, foi identificada a estrutura SARS-Cov-2, além disso, a patologia causada por esse vírus foi nomeada como COVID-19. O período de incubação desta doença é algo cerca de 4 ou 5 dias antes do início dos sintomas, com 97,5% dos pacientes tendo 11,5 dias de sintomas próximos. Além disso, os pacientes afetados estão tendo manifestações cutâneas, além do afeto pulmonar, laboratorial e sistêmico clássico. Assim, o objetivo do presente artigo foi a descrição das manifestações clínicas, cutâneas e laboratoriais em adultos de 18 a 59 anos afetados pelo COVID19 e apoiados pelo Hospital São Rafael, localizado em Altamira-Pará, região do Amazona

Educar para empoderar: o uso de tecnologias educativas para o controle e prevenção de infecção hospitalar / Educating to empower: the use of educational technologies for hospital infection control and prevention

Objetivo: Avaliar a utilização de tecnologias educativas na prevenção e controle de infecções hospitalares em um centro de terapia intensiva (CTI) de um Hospital Público de Ensino de Belém do Pará. Método: estudo de intervenção, realizado com profissionais da saúde do CTI, por meio de atividades de educação em serviço com auxílio de tecnologias educativas, tais como cartilhas e cartazes. Resultados: o uso das tecnologias educativas possibilitou a aprendizagem de novas regras e melhoria no conhecimento pré-existente dos participantes, também garantiu empoderamento nas ações e tomadas de decisões, quanto a prevenção e controle das infecções. Portanto, pode-se sugerir a eficácia da tecnologia educativa ao processo de aprendizagem, visto que, houve um maior segmento de regras previstas nas cartilhas e cartazes educativos e, consequentemente, redução das taxas de infecção no setor investigado. Além disso, os participantes consideraram positivo o uso desse tipo de tecnologia, principalmente, aquelas relacionadas à higienização das mãos. Conclusão: As tecnologias educativas utilizadas apresentaram um resultado eficaz no processo de aprendizagem dos profissionais de saúde, relacionando-se com a futura redução das taxas de controle de infecções do hospital estudado. Contudo, futuras investigações podem verificar o efeito temporal dessas medidas, além de testarem novas tecnologias educacionais

Meta-analysis: hydroxychloroquine therapy approach with or without azithromycin against covid-19

Objective: identify and analyse the evidences about the use of hydroxychloroquine with or without azithromycin in covid-19. Methods: This is a systematic review with meta-analysis using posted articles in December 2019 until May 2020. The research was formulated by a question structured using PICO strategy, in these data bases: BVS, PUBMED, MEDLINE, LILACS, BDENF e SCIELO. Results and discussion: Resulted in 9 articles founded by the PRISMA, approaching 4182 patients. PICO strategy selected and analysed 5 articles projected in Forest plots. Resulting in tree clinical trials (RR: 1.15; IC95%, 0.76 a 1.73), which did not found big differences in the outcome in the groups of patients who used HCQ with or without AZT, comparing with the control group. Two studies analysed the number of deaths/intubations in comparative group, experimental group and control (RR:1.86; IC: 95%, 1.54 a 2.26) resulting in more chance of death /intubation in patients who used HCQ. Conclusion: It was found that is not possible to prove the efficacy of these drugs, due to the limited number of randomized and controlled clinical trials. Therefore, the encourage of scientific production about the HCQ and AZT against Covid-19 is more than necessary

Catálogo Taxonômico da Fauna do Brasil: setting the baseline knowledge on the animal diversity in Brazil

The limited temporal completeness and taxonomic accuracy of species lists, made available in a traditional manner in scientific publications, has always represented a problem. These lists are invariably limited to a few taxonomic groups and do not represent up-to-date knowledge of all species and classifications. In this context, the Brazilian megadiverse fauna is no exception, and the Catálogo Taxonômico da Fauna do Brasil (CTFB) (http://fauna.jbrj.gov.br/), made public in 2015, represents a database on biodiversity anchored on a list of valid and expertly recognized scientific names of animals in Brazil. The CTFB is updated in near real time by a team of more than 800 specialists. By January 1, 2024, the CTFB compiled 133,691 nominal species, with 125,138 that were considered valid. Most of the valid species were arthropods (82.3%, with more than 102,000 species) and chordates (7.69%, with over 11,000 species). These taxa were followed by a cluster composed of Mollusca (3,567 species), Platyhelminthes (2,292 species), Annelida (1,833 species), and Nematoda (1,447 species). All remaining groups had less than 1,000 species reported in Brazil, with Cnidaria (831 species), Porifera (628 species), Rotifera (606 species), and Bryozoa (520 species) representing those with more than 500 species. Analysis of the CTFB database can facilitate and direct efforts towards the discovery of new species in Brazil, but it is also fundamental in providing the best available list of valid nominal species to users, including those in science, health, conservation efforts, and any initiative involving animals. The importance of the CTFB is evidenced by the elevated number of citations in the scientific literature in diverse areas of biology, law, anthropology, education, forensic science, and veterinary science, among others